Anti-IGF1R / CD221 Reference Antibody (figitumumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-IGF1R / CD221 Reference Antibody (figitumumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-IGF1R / CD221 Reference Antibody (dalotuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-IGF1R / CD221 Reference Antibody (ganitumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-IGF1R / CD221 Reference Antibody (Immunomedics patent anti-IGF-1R)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-IGF1R / CD221 Reference Antibody (Lonigutamab-MMAE)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-IGF1R / CD221 Reference Antibody (lonigutamAb)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-IGF1R / CD221 Reference Antibody (cixutumumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse |
Anti-IGF1R / CD221 Reference Antibody (teprotumumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-IGF1R / CD221 Reference Antibody (robatumumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |